Publications

Add filters (0)

70 results

Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes.

April 10, 2018

Arthritis Res Ther

Abstract BACKGROUND Osteoclasts have been strongly implicated in osteoarthritic cartilage degradation, at least indirectly via bone resorption, and have been shown to degrade cartilage in vitro. The osteoclast resorption processes required to degrade subchondral bone and cartilage-the remodeling of which is important in the osteoarthritic disease process-have not been previously described, although cathepsin K has […]

Read publication

Biochemical marker discovery, testing and evaluation for facilitating OA drug discovery and development.

February 1, 2018

Drug Discov Today

Abstract Osteoarthritis (OA) is the most common form of joint disease. This presents the OA research community and pharmaceutical companies developing disease-modifying OA drugs (DMOADs) with great opportunities. The different OA subtypes complicate the traditional approaches for developing new treatments. If we can identify new markers that can distinguish different subtypes this could greatly facilitate […]

Read publication

Development and use of biochemical markers in osteoarthritis: current update.

January 1, 2018

Curr Opin Rheumatol

Abstract PURPOSE OF REVIEW There is an increasing demand for noninvasive and descriptive biochemical markers (biomarkers) in osteoarthritis; for enabling early drug development (including translational research), evaluating clinical trial at an early stage and for subtyping. Purpose of the review is to review and comment on current availability of such biomarkers. RECENT FINDINGS Many different […]

Read publication

Soluble biochemical markers of osteoarthritis: Are we close to using them in clinical practice?

October 1, 2017

Best Pract Res Clin Rheumatol

Abstract Osteoarthritis (OA) is the most common form of arthritis and a major cause of pain and disability. Recent work suggests that the global burden of OA is increasing, and costs associated with treatment are expected to increase dramatically as the aging human population expands. OA is currently diagnosed using radiography, but this technique is […]

Read publication

The minor collagens in articular cartilage.

August 1, 2017

Protein Cell

Abstract Articular cartilage is a connective tissue consisting of a specialized extracellular matrix (ECM) that dominates the bulk of its wet and dry weight. Type II collagen and aggrecan are the main ECM proteins in cartilage. However, little attention has been paid to less abundant molecular components, especially minor collagens, including type IV, VI, IX, […]

Read publication

Chondrocyte secretome: a source of novel insights and exploratory biomarkers of osteoarthritis.

August 1, 2017

Osteoarthritis Cartilage

Abstract The extracellular matrix (ECM) of articular cartilage is comprised of complex networks of proteins and glycoproteins, all of which are expressed by its resident cell, the chondrocyte. Cartilage is a unique tissue given its complexity and ability to resist repeated load and deformation. The mechanisms by which articular cartilage maintains its integrity throughout our […]

Read publication

Osteoarthritis Year in Review 2016: biomarkers (biochemical markers).

February 1, 2017

Osteoarthritis Cartilage

Abstract PURPOSE The aim of this “Year in Review” article is to summarize and discuss the implications of biochemical marker related articles published between the Osteoarthritis Research Society International (OARSI) 2015 Congress in Seattle and the OARSI 2016 Congress in Amsterdam. METHODS The PubMed/MEDLINE bibliographic database was searched using the combined keywords: ‘biomarker’ and ‘osteoarthritis’. […]

Read publication

Osteoarthritis biomarkers derived from cartilage extracellular matrix: Current status and future perspectives.

June 1, 2016

Ann Phys Rehabil Med

Abstract Specific soluble biomarkers can be powerful tools for the diagnosis, prognosis and personalized management of osteoarthritis (OA). Biomarkers are potential indicators of the effect of a drug on cartilage metabolism and provide crucial information about the mechanisms of drug action. In this review, we address key questions concerning the use of biomarkers in OA […]

Read publication

Association between biomarkers of tissue inflammation and progression of osteoarthritis: evidence from the Rotterdam study cohort.

April 1, 2016

Arthritis Res Ther

Abstract BACKGROUND We aimed to investigate the prognostic value of two biomarkers of tissue inflammation, matrix metalloproteinase-dependent degradation of C-reactive protein (CRPM) and connective tissue type I collagen turnover (C1M), on the incidence and progression of radiographic osteoarthritis (OA) in the Rotterdam Study, a prospective cohort. Moreover, the independent effect of these biomarkers with respect […]

Read publication